CCO Infectious Disease Podcast

Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021

Episode Summary

Listen to expert insights from Nancy Reau, MD, on updates and new viral hepatitis data from AASLD 2021, including HBV treatment in pregnancy, outcomes following HBV treatment withdrawal, progress toward HBV cure, HCV implementation science and the cascade of care, characterization of the population with hepatitis delta, and phase III clinical trial updates for hepatitis delta.

Episode Notes

In this episode, Nancy Reau, MD, discusses new viral hepatitis data from AASLD 2021, including:

• HBV treatment in pregnancy
• Outcomes following HBV treatment withdrawal  
• Progress toward an HBV cure
• HCV implementation science and current status of the cascade of care
• Hepatitis delta virus: understanding the clinical impact
• Phase III clinical trial updates for hepatitis delta virus, including data on bulevirtide

Presenter:  

Nancy Reau, MD
Professor of Medicine  
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Follow along with the downloadable slideset at:
https://bit.ly/3d6NQRV

Link to full program:
https://bit.ly/3lputrT